Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss how medical mistrust has impacted participation in oncology clinical trials.
Biomedical concepts by CDISC are tailored to ensure data consistency, and link information throughout the data pipeline.
The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.
Florence has been issuing its State of Technology Enabled Clinical Trials Report for five years now, so there is contextual ...